CYP2C9 Recombinant Antibody

$25 ug total protein per lane of various lysates (see on figure) probed with CYP2C9 monoclonal antibody, unconjugated (bsm-61843R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

25 ug total protein per lane of various lysates (see on figure) probed with CYP2C9 monoclonal antibody, unconjugated (bsm-61843R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

WB
FCM
IF(ICC)

Reactivity

Human

Overview
Catalog #	bsm-61843r-100ul
Product Name	CYP2C9 Recombinant Antibody
Applications	WB, FCM, IF(ICC)
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Cytochrome P450 2C9
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	1559
Swiss Prot	P11712
Subcellular location	Cytoplasm
Synonyms	CPC9; CYP2C; CYP2C10; CYP2C9; CYPIIC9; P450 PB1; P450MP.
Background	A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and steroids.
Application Dilution
WB	1:500-2000
FCM	FCM1:50-100
IF(ICC)	IFICC1:50-200